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Abstract
Background: Gold nanoparticles (GNPs) have important application for cell labeling and imaging, drug delivery,
diagnostic and therapeutic purposes mainly in cancer. Nanoparticles (NPs) are being increasingly exploited for
medical applications. The aim of the present study was to investigate the particle-size and period effects of
administration of GNPs on the renal tissue in an attempt to address their potential toxicity.
Methods: A total of 70 healthy male Wistar-Kyoto rats were exposed to GNPs received 50 or 100 μl of GNPs infusion
of size (10, 20 and 50 nm for 3 or 7 days) to investigate particle-size effect of GNPs on the renal tissue. Animals were
randomly divided into groups, 6 GNPs-treated rats groups and one control group. Groups 1, 2 and 3 received
infusion of 50 μl GNPs of size 10 nm (3 or 7 days), size 20 nm (3 or 7 days) and 50 nm (3 or 7 days), respectively;
while groups 4, 5 and 6 received infusion of 100 μl GNPs of size 10 nm, size 20 nm and 50 nm, respectively. Stained
sections of control and treated rats kidneys were examined for renal tissue alterations induced by GNPs.
Results: In comparison with respective control rats, exposure to GNPs doses has produced the following renal
tubular alterations: cloudy swelling, vacuolar degeneration, hyaline droplets and casts, anisokaryosis, karopyknosis,
karyorrhexis and karyolysis. The glomeruli showed moderate congestion with no hypercelluraity, mesangial
proliferation or basement membrane thickening. The histological alterations were mainly seen in the cortex and
the proximal renal convoluted tubules were more affected than the distal ones.
Conclusions: The induced histological alterations might be an indication of injured renal tubules due to GNPs
toxicity that became unable to deal with the accumulated residues resulting from metabolic and structural
disturbances caused by these NPs. The findings may suggest that GNPs interact with proteins and enzymes of the
renal tissue interfering with the antioxidant defense mechanism and leading to reactive oxygen species (ROS)
generation which in turn may induce stress in the renal cells to undergo atrophy and necrosis. The produced
alterations were size-dependent with smaller ones induced more affects and related with time exposure of GNPs.
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Introduction
Nanoparticles are an intermediate state of matter some-
where between bulk and molecular level. These particles
have important application for cell labeling and imaging,
drug delivery, biological sensors, diagnostic and thera-
peutic purposes mainly in cancer and photodynamic
therapy [1-6]. Studies revealed that the NPs were rapidly
taken into the system with the highest accumulation in
the liver, spleen, lungs, aorta, esophagus and olfactory
bulb [7]. Moreover, particles of nano-dimension are
believed to be more biologically reactive than their bulk
counter parts due to their small size and larger surface
area to volume ratio [7,8].
Gold in its bulk form has long been considered an
inert, noble metal with some therapeutic and even med-
icinal value hence GNPs are thought also to be relatively
non-cytotoxic [9]. Yet there are differing reports of the
extent of the toxic nature of these particles owing to
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their different modifications, surface functional attach-
ments, shape and size [10,11]. Moreover, the metallic
nature of the metal derived NPs and the presence of tran-
sition metals encourages the production of reactive oxy-
gen species (ROS) leading to oxidative stress [12,13].
Although some scientists consider NPs as nontoxic,
there are other studies reporting the toxic effects of NPs
[14-16]. While some NPs may appear to be nontoxic,
other cellular mechanisms such as cell signaling and
other normal cellular functions may be disrupted and are
currently undergoing further investigation [17,18]. The
toxicity of NPs is being addressed by a number of stan-
dardized approaches with in vitro, in vivo as well as
detailed genomic or biodistribution studies [18]. In addi-
tion, it has been shown that NPs may produce in vitro
toxicity in some cell-based assays, but not in others. This
may be a result of interference with the chemical probes,
differences in the innate response of particular cell types,
or other factors, a point to be considered when GNPs are
used as carriers for the delivery of drugs and in gene
therapy [19,20].
While nanotoxicity research is now gaining attention,
little is paid to the effect of GNPs size mainly to their dis-
tribution and alterations in the tissue [21,22]. The histo-
logical and the histochemical alterations in the renal
tissues due to GNPs have not well documented and have
not yet been identified. In the present study, an attempt
has been made to address the possible histological altera-
tions in the renal tissues following exposure to GNPs and
whether the potential nanotoxicity is related to the size
of these particles and the time of exposure.
Materials and Methods
A total of 70 healthy male Wistar-Kyoto rats obtained
from the Laboratory Animal Center (College of Pharmacy,
King Saud University, Saudi Arabia). The rats nearly of the
same age (12 weeks old) and weighing 220-240 gm of
King Saud University colony were used. Animals were ran-
domly divided into groups, 6 GNPs-treated rats groups
and one control group. Following a period of stabilization
(7 days), 10, 20 and 50 nm GNPs were administered intra-
peritonealy at the rate for 3 or 7 days as follows: Group 1:
received infusion of 50 μl GNPs of size 10 nm for 3 or 7
days (n = 10); Group 2: received infusion of 50 μl GNPs of
size 20 nm for 3 or 7 days (n = 10); Group 3: received
infusion of 50 μl GNPs of size 50 nm for 3 or 7 days (n =
10); Group 4: received infusion of 100 μl GNPs of size 10
nm for 3 or 7 days; (n = 10); Group 5: received infusion of
100 μl GNPs of size 20 nm for 3 or 7 days (n = 10); Group
6: received infusion of 100 μl GNPs of size 50 nm for 3 or
7 days; (n = 10); Control group: received no gold nanopar-
ticles (n = 10).
The rats were maintained on standard laboratory
rodent diet pellets and were housed in humidity and
temperature-controlled ventilated cages on a 12 h day/
night cycle. Two animals from each group were killed
by dislocation of the neck at intervals of 3 and 7 days of
treatment with GNPs. All experiments were conducted
in accordance with the guidelines approved by King
Saud University Local Animal Care and Use Committee.
Fresh portions of both kidneys from each rat were cut
rapidly, fixed in neutral buffered formalin (10%), then
dehydrated, with grades of ethanol (70, 80, 90, 95 and
100%). Dehydration was then followed by clearing the
samples in 2 changes of xylene. Samples were then
impregnated with 2 changes of molten paraffin wax, then
embedded and blocked out. Paraffin sections (4-5 um)
were stained with hematoxylin and eosin stain according
to Pearse [23]. Stained sections of control and treated
rats were examined for alterations in renal tissue.
Results and Discussions
No mortality occurred in any of the experimental groups
of the present investigation, and no alterations were
observed in the appearance and behavior of GNPs treated
rats in comparison with the control ones. In comparison
with the control group, the following histological altera-
tions were detected in the renal tissue of GNPs treated
rats:
Glomerular alterations
GNPs produced occasional glomerular congestion in the
rats exposed to 10 nm or 20 nm particles for 7 days but not
in the glomeruli of the rats exposed to 50 nm (Figure 1).
No hypercellularity, mesangial proliferation or glomerular
basement membranes thickening were detected in the glo-
meruli of all GNPs treated rats. Occasional dilatation of
glomerular tuft blood capillaries was observed. These little
alteration showed by the glomeruli might be due to the
glomerular basement membrane which forms a barrier that
Figure 1 GNPs-treated rat received 50 μl of 10 nm particles for
3 days demonstrating glomerular congestion (arrow).
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prevents nanoparticles accumulation. Terentyuk et al., 2009
[24] reported proliferation of epithelial cells of Bowman’s
capsule by GNPs where 15 nm particles showed more effect
than larger ones.
Tubular alterations
The following tubular alterations due to GNPs intoxica-
tion appeared in the renal tissue of the treated rats.
Cloudy swelling: renal tubules epithelial lining exhib-
ited cloudy swelling with pale cytoplasm and poorly deli-
neated and displaced nuclei in all GNPs treated rats. This
alteration was more prominent in the proximal convoluted
tubules than the distal ones and with more swelling with
100 μl dose than 50 μl one and with 10 nm and 20 nm
size particles than the larger ones (Figure 2). Cytoplasmic
swelling might be exhibited as a result of disturbances of
membranes function that lead to massive influx of water
and Na+ due to GNPS effects. This alteration might be
accompanied by leakage of liposome hydrolytic enzymes
that lead to cytoplasmic degeneration and macromolecular
crowding [25].
Vacuolar degeneration: vacuolization of the renal
cells was seen and increased in severity in the renal
tubules of rats received 100 μl of 10 or 20 nm GNPs
with less or no vacuolar degeneration with 50 nm parti-
cles. More vacuolar degeneration was observed in the
renal cells of rats exposed to 7 days than ones exposed
to 3 days (Figures 3 and 4). The proximal renal tubules
were more affected than the distal ones that became
flattened. This could be due to the fact that the proxi-
mal convoluted tubules are the primary sites of reab-
sorption and active transport leading to higher
concentration of the nanoparticles specially the smaller
ones in the epithelial lining of these tubules. Vacuolated
degeneration is a result of ion and fluid homestasis that
lead to an increase of intracellular water [26]. The
vacuolated swelling of the cytoplasm of the renal cells of
the GNPs treated rats might indicate acute and subacute
renal injury induced by these NPs.
Hyaline droplets: hyaline droplets were detected in
the renal epithelium of rats received 100 μl of 10 or 20
nm GNPs (Figure 5). Droplets appearance is associated
with protein metabolism disturbances. This alteration
was not seen in the renal tissue of rats exposed to 50
nm particles. Hyaline casts were also seen in the lumen
of some distal convoluted renal tubules (Figure 6).
Anisokaryosis: variable nuclei sizes were observed in
some renal cells. This change became apparent after 7
days of 50 nm GNPs administration (Figure 7). Some
studies indicate that nuclear polymorphism is seen in
dysplasia and carcinomatous lesion [27].
Figure 2 GNPs-treated rat received 100 μl of 10 nm particles
for 7 days demonstrating cloudy swelling of the renal cells
(stars).
Figure 3 GNPs-treated rat received 50 μl of 10 nm particles for
3 days showing vacuolar degeneration (stars).
Figure 4 GNPs-treated rat received 100 μl of 20 nm particles
for 7 days demonstrating vacuolar degeneration (stars).
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Nuclear pyknosis: sections of GNPs-treated kidneys
developed pyknosis in some epithelium lining cells of
the proximal tubules with lesser extent in the distal
ones. This alteration was seen in all GNPs-treated rats
with 10 and 20 nm particles (Figure 8). Pyknotic nuclei
exhibited clumping and condensation of the chromatin
materials in the periphery of the nuclei together with
irregularity nuclear membranes. Karyopyknosis is an
irreversible condensation of chromatin in the nucleus of
a cell undergoing necrosis or apoptosis [28].
Karyorrhexis: some renal cells of rats received 10 and
20 nm GNPs showed nucleoli disappearance (Figure 9).
This nuclear damage was more prominent after
7 days of exposure to NPs. Karyorrhexis is a sort of
destructive fragmentation of the nucleus proceeded by
pyknosis and is followed by karyolysis [29].
Karyolysis: this alteration appeared mainly in the kid-
ney of GNPs-treated rats exposed to 100 μl of 20 nm
size particles (Figure 10). Karyolysis is the complete dis-
solution of the chromatin matter of a dying cell [30].
The renal tissue of the rats received 50 or 100 μl of 50
nm Au NPs for 3 or 7 days showed little or no altera-
tions while none of the above alterations were observed
in the renal tissue of any member of the control group
(Figures 11 & 12).
Conclusions
Histological alterations by GNPs exposure as shown in
the results of the present work could be an indication of
injured renal tissue due to GNPs toxicity that become
unable to deal with the accumulated residues resulting
from metabolic and structural disturbances caused by
these particles. One might conclude that these alterations
are size-dependent with smaller ones induced more
damage to renal tissue with relation to the time exposure
Figure 5 GNPs-treated rat received 50 μl of 10 nm particles for
3 days demonstrating hyaline droplets in the cytoplasm of the
renal cells (arrows).
Figure 6 GNPs-treated rat received 100 μl of 20 nm particles
for 7 days demonstrating hyaline casts in some distal tubules
(arrows).
Figure 7 GNPs-treated rat received 10 μl of 20 nm particles for
7 days demonstrating anisokaryosis (arrows).
Figure 8 GNPs-treated rat received 100 μl of 50 nm particles
for 7 days demonstrating karyopyknosis.
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of GNPs. This might be due to earlier accumulation of
the larger NPs in the tissue while the smaller ones stay
much longer in the blood stream due to recirculation.
The appearance of renal cells cytoplasmic degenera-
tion and nuclear destruction may suggest that GNPs
interact with proteins and enzymes of the renal tissue
interfering with the antioxidant defense mechanism and
leading to generation and accumulation of the reactive
oxygen species (ROS) which in turn may inflammatory
response and mitochondrial destruction inducing stress
in the renal cells to undergo atrophy and necrosis and
programmed cell death.
More histomorphologcal, histochemical and ultrastru-
cural investigations are needed to correlate the biomedi-
cal application of GNPs with the potential threat of
their therapeutic and diagnostic use in correlation with
the size, chemical composition, surface charge, solubility
and surface structure of these particles.
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Figure 9 GNPs-treated rat received 100 μl of 20 nm particles
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Figure 10 GNPs-treated rat received 50 μl of 20 nm particles
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Figure 12 GNPs-treated rat received 100 μl of 50 nm particles
for 7 days demonstrating normal renal tubules.
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